Matches in Nanopublications for { <http://rdf.disgenet.org/resource/nanopub/NP1393963.RAyiXTOLWQpc74w5Rhz5iDPOyoH-GvyV9jVcFh3hOHDiw130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP1393963.RAyiXTOLWQpc74w5Rhz5iDPOyoH-GvyV9jVcFh3hOHDiw130_assertion type Assertion NP1393963.RAyiXTOLWQpc74w5Rhz5iDPOyoH-GvyV9jVcFh3hOHDiw130_head.
- NP1393963.RAyiXTOLWQpc74w5Rhz5iDPOyoH-GvyV9jVcFh3hOHDiw130_assertion description "[When criteria for positivity were matched with those in common use for immunohistochemical studies, 28 of 94 (30%) breast cancers were classified as positive for Her-2/neu overexpression.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP1393963.RAyiXTOLWQpc74w5Rhz5iDPOyoH-GvyV9jVcFh3hOHDiw130_provenance.
- NP1393963.RAyiXTOLWQpc74w5Rhz5iDPOyoH-GvyV9jVcFh3hOHDiw130_assertion evidence source_evidence_literature NP1393963.RAyiXTOLWQpc74w5Rhz5iDPOyoH-GvyV9jVcFh3hOHDiw130_provenance.
- NP1393963.RAyiXTOLWQpc74w5Rhz5iDPOyoH-GvyV9jVcFh3hOHDiw130_assertion SIO_000772 9563885 NP1393963.RAyiXTOLWQpc74w5Rhz5iDPOyoH-GvyV9jVcFh3hOHDiw130_provenance.
- NP1393963.RAyiXTOLWQpc74w5Rhz5iDPOyoH-GvyV9jVcFh3hOHDiw130_assertion wasDerivedFrom befree-2016 NP1393963.RAyiXTOLWQpc74w5Rhz5iDPOyoH-GvyV9jVcFh3hOHDiw130_provenance.
- NP1393963.RAyiXTOLWQpc74w5Rhz5iDPOyoH-GvyV9jVcFh3hOHDiw130_assertion wasGeneratedBy ECO_0000203 NP1393963.RAyiXTOLWQpc74w5Rhz5iDPOyoH-GvyV9jVcFh3hOHDiw130_provenance.